Today: 20 March 2026
Browse Category

XETRA:EOAN 10 November 2025 - 27 November 2025

E.ON SE Stock Today (27 November 2025): Price Falls on Goldman Sachs Target Cut as EU Backs New Truck‑Charging Network

E.ON SE Stock Today (27 November 2025): Price Falls on Goldman Sachs Target Cut as EU Backs New Truck‑Charging Network

E.ON SE shares fell about 2.5% to €15.13 on 27 November after Goldman Sachs cut its price target to €17.50, citing concerns over German grid regulation. The utility announced a €70.3 million EU-backed truck charging project and expanded its solar business in the UK. E.ON reported adjusted EBITDA of €7.4 billion for the first nine months of 2025, up 10% year-on-year.
E.ON and RWE confirm 2025 outlooks as profits hold up — RWE stock pops on AI data‑centre momentum (Nov 12, 2025)

E.ON and RWE confirm 2025 outlooks as profits hold up — RWE stock pops on AI data‑centre momentum (Nov 12, 2025)

E.ON reaffirmed its 2025 outlook and reported a 10% rise in nine-month core profit, driven by increased grid investment. RWE beat profit forecasts after a €225 million gain from selling a UK data-centre project and said it is assessing more such projects in Europe. RWE shares hit a 52-week high, rising over 3% in early trading. Both utilities maintained their full-year 2025 guidance.
$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

DAX Today (10 November 2025): German Stocks Jump on U.S. Shutdown Progress; Siemens Energy, Commerzbank, Hannover Re Lead Gains

Germany’s DAX jumped 1.8% to around 23,990 by late morning Monday as U.S. Senate progress on ending a 40-day government shutdown lifted global markets. Siemens Energy and Commerzbank rose about 5% after upgrades, while Hannover Re gained up to 4% on higher guidance. E.ON and Deutsche Telekom slipped. Eurozone Sentix morale dropped to −7.4, and Germany’s chemical sector sentiment hit a 30-year low.

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop